Petmed Express Inc (NASDAQ:PETS) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 9,175,300 shares, a growth of 5.5% from the April 15th total of 8,695,000 shares. Currently, 46.2% of the shares of the company are short sold. Based on an average daily volume of 628,400 shares, the short-interest ratio is presently 14.6 days.
Separately, BidaskClub raised YY from a “strong sell” rating to a “sell” rating in a research report on Thursday, May 30th.
PETS traded up $0.08 during midday trading on Friday, hitting $15.09. 687,397 shares of the company were exchanged, compared to its average volume of 631,398. Petmed Express has a 1-year low of $15.00 and a 1-year high of $41.76. The stock has a market cap of $303.55 million, a price-to-earnings ratio of 8.16 and a beta of 0.52. The business has a 50 day moving average of $16.70.
Several large investors have recently bought and sold shares of PETS. Manchester Capital Management LLC grew its position in shares of Petmed Express by 185.8% during the 1st quarter. Manchester Capital Management LLC now owns 1,938 shares of the company’s stock valued at $44,000 after acquiring an additional 1,260 shares during the period. Financial Gravity Wealth Inc. acquired a new stake in shares of Petmed Express during the 1st quarter valued at about $49,000. Kessler Investment Group LLC grew its position in shares of Petmed Express by 159.8% during the 1st quarter. Kessler Investment Group LLC now owns 3,336 shares of the company’s stock valued at $76,000 after acquiring an additional 2,052 shares during the period. Advisory Services Network LLC grew its position in shares of Petmed Express by 39.3% during the 4th quarter. Advisory Services Network LLC now owns 3,543 shares of the company’s stock valued at $82,000 after acquiring an additional 1,000 shares during the period. Finally, FMR LLC grew its position in shares of Petmed Express by 9,448.1% during the 1st quarter. FMR LLC now owns 5,156 shares of the company’s stock valued at $118,000 after acquiring an additional 5,102 shares during the period. Hedge funds and other institutional investors own 99.63% of the company’s stock.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Article: Asset Allocation
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.